Not logged in Share Save
Share Save
Share Save
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study von Mehren, Margaret; George, Suzanne; Heinrich, Michael C.; Schuetze, Scott M.; Yap, Jeffrey T.; Yu, Jain Q.; Abbott, Amanda; Litwin, Samuel; Crowley, John; Belinsky, Martin; Janeway, Katherine A.; Hornick, Jason L.; Flieder, Douglas B.; Chugh, Rashmi; Rink, Lori; Van den Abbeele, Annick D. Share Save
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials Ailawadhi, Sikander; Jacobus, Susanna; Sexton, Rachael; Stewart, Alexander K.; Dispenzieri, Angela; Hussein, Mohamad A.; Zonder, Jeffrey A.; Crowley, John; Hoering, Antje; Barlogie, Bart; Orlowski, Robert Z.; Rajkumar, S. Vincent Share Save
Project Survival: Year 3 update on a 7-year prospective clinical study driven by quality metrics, multi-omic analysis and artificial intelligence to develop translational biomarkers for pancreatic cancer Grund, Eric Michael; Kiebish, Michael A.; Akmaev, Viatcheslav R.; Sarangarajan, Rangaprasad; Crowley, John; Stoll-D'Astice, Amy; Singer, Tori; Decicco, Corrine; Hori, Wendy; Bussberg, Valerie; Diedrich, Karl; Rodrigues, Leonardo; Chen, Emily; Vishnudas, Vivek; Najarian, Robert; Dragovich, Tomislav; Hidalgo, Manuel; Narain, Niven; Moser, A. James Share Save
Share Save
Project Survival: Prospective clinical study utilizing multiomics and artificial intelligence to discover novel molecular markers for detection, stratification, and outcome in pancreatic cancer Sarangarajan, Rangaprasad; Crowley, John; Stoll-D'Astice, Amy; Bussberg, Valerie; Nguyen, Cindy; Rodrigues, Leonardo O.; Chen, Emily; Grund, Eric Michael; Vishnudas, Vivek K.; Kiebish, Michael; Akmaev, Viatcheslav R.; Hidalgo, Manuel; Narain, Niven R.; Moser, A. James Share Save
Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants Jethava, Yogesh S.; Mitchell, Alan; Epstein, Joshua; Zangari, Maurizio; Yaccoby, Shmuel; Tian, Erming; Waheed, Sarah; Khan, Rashid; Papanikolaou, Xenofon; Grazziutti, Monica; Cottler-Fox, Michele; Petty, Nathan; Steward, Douglas; Panozzo, Susan; Bailey, Clyde; Hoering, Antje; Crowley, John; Sawyer, Jeffrey; Morgan, Gareth; Barlogie, Bart; van Rhee, Frits Share Save
Share Save
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma Jethava, Y.; Mitchell, A.; Zangari, M.; Waheed, S.; Schinke, C.; Thanendrarajan, S.; Sawyer, J.; Alapat, D.; Tian, E.; Stein, C.; Khan, R.; Heuck, Cj; Petty, N.; Avery, D.; Steward, D.; Smith, R.; Bailey, C.; Epstein, J.; Yaccoby, S.; Hoering, A.; Crowley, J.; Morgan, G.; Barlogie, B.; van Rhee, F. Share Save
Project Survival: Interrogative Biology® platform mediated discovery of molecular markers for detection, stratification and outcomes in pancreatic cancer Narain, Niven R.; Moser, A. James; Ramanathan, Ramesh; Crowley, John; Stoll-D'Astice, Amy; Sun, Yezhou; Rodrigues, Leonardo O.; Grund, Eric M.; Chen, Emily; Vishnudas, Vivek K.; Kiebish, Michael A.; Akmaev, Viatcheslav R.; Sarangarajan, Rangaprasad Share Save
Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120) Papanikolaou, X.; Rosenthal, A.; Dhodapkar, M.; Epstein, J.; Khan, R.; van Rhee, F.; Jethava, Y.; Waheed, S.; Zangari, M.; Hoering, A.; Crowley, J.; Alapat, D.; Davies, F.; Morgan, G.; Barlogie, B. Share Save
High complete and partial response rate in a phase Ib pilot trial with cisplatin plus albumin-bound paclitaxel and gemcitabine in patients with advanced pancreatic cancer Jameson, Gayle S.; Borazanci, Erkut; Poplin, Elizabeth; Barrett, Michael T.; Crowley, John; Rosenthal, Adam; Stoll-D'Astice, Amy; AnsaIdo, Karen L.; Boone, Steven; Lebron, Leticia; Ramanathan, Ramesh K.; Kom, Ronald L.; Von Hoff, Daniel D. Share Save
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG 50120) Khan, Rashid; Dhodapkar, Madhav; Rosenthal, Adam; Heuck, Christoph; Papanikolaou, Xenofon; Qu, Pingping; van Rhee, Frits; Zangari, Maurizio; Jethava, Yogesh; Epstein, Joshua; Yaccoby, Shmuel; Hoering, Antje; Crowley, John; Petty, Nathan; Bailey, Clyde; Morgan, Gareth; Barlogie, Bart Share Save
Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma Khan, R.; Apewokin, S.; Grazziutti, M.; Yaccoby, S.; Epstein, J.; van Rhee, F.; Rosenthal, A.; Waheed, S.; Usmani, S.; Atrash, S.; Kumar, S.; Hoering, A.; Crowley, J.; Shaughnessy, J. D., Jr.; Barlogie, B. Share Save
Share Save
Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma Heuck, C. J.; Qu, P.; van Rhee, F.; Waheed, S.; Usmani, S. Z.; Epstein, J.; Zhang, Q.; Edmondson, R.; Hoering, A.; Crowley, J.; Barlogie, B. Share Save
Share Save
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma Papanikolaou, Xenofon; Szymonifka, Jackie; Rosenthal, Adam; Heuck, Christoph J.; Mitchell, Alan; Johann, Donald, Jr.; Keller, Jason; Waheed, Sarah; Usmani, Saad Z.; Van Rhee, Frits; Bailey, Clyde; Petty, Nathan; Hoering, Antje; Crowley, John; Barlogie, Bart Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
